Stentys SA (EPA:STNT) is looking to branch out in Europe, seeking new markets for its stents designed to treat heart attacks.
The Princeton, N.J.-based company said it’s launching its products in Scandinavia, Spain, Switzerland and Poland. The devices are already on the market in Germany and the Netherlands, according to co-founder and CEO Gonzague Issenmann.
Sales grew 66.7 percent during the fourth quarter for Stentys, compared with the third quarter, according to a press release. The company attributed the boost to “increased physician acceptance in Germany and the Netherlands.” Full financial results for Q4 and full-year 2010 are slated to drop March 24.